Mount Sinai researchers have identified sweet-sensing taste receptors T1R3 and G protein gustducin in the human intestine. The discovery may lead to new treatments for obesity and diabetes.
The two taste receptors, which are critical to sweet taste in the tongue, are also expressed in specialized taste cells of the gut where they sense glucose within the intestine.
The small intestine is the major site where dietary sugars are absorbed into the body to provide energy, and maintain normal metabolism and homeostasis. If glucose is absorbed in excess obesity may occur.
The study found that T1R3 and gustducin, critical to sweet taste in the tongue, were also expressed in specialized taste cells of the gut where they sensed glucose within the intestine.
Researchers noted that carbohydrate ingested from meals and beverages broke down into glucose, which stimulated the sweet-sensing proteins in these gut taste cells. Activating the sweet-sensing proteins of the gut taste cells promoted secretion of glucagon-like peptide-1 (GLP-1), an intestinal hormone that plays a key role in promoting insulin secretion and regulating appetite.
"We now know that the receptors that sense sugar and artificial sweeteners are not limited to the tongue. Our work is an important advance for the new field of gastrointestinal chemosensation - how the cells of the gut detect and respond to sugars and other nutrients. Cells of the gut taste glucose through the same mechanisms used by taste cells of the tongue.
The gut taste cells regulate secretion of insulin and hormones that regulate appetite. Our work sheds new light on how we regulate sugar uptake from our diets and regulate blood sugar levels," Margolskee said.
The findings of the study were published online in the August ' "Early Edition' of the Proceedings of the National Academy of Sciences.